Clinical Trials Logo

Clinical Trial Summary

Core elements of effective antibiotic stewardship programs (ASPs) have been identified and evidence-based guidelines have been developed for implementation. The majority of the evidence used for these guidelines are from published studies on the effectiveness of ASPs in large academic or large community hospitals. A significant portion of healthcare in the United States, however, takes place in small hospitals. In 2015, 73% of US hospitals had < 200 beds (4,057 hospitals) and accounted for 29% of all US inpatient bed days. Limited studies on the effectiveness of antibiotic stewardship implementation have been performed in hospitals with < 200 beds. Antibiotic use rates and selection patterns in these small hospitals are similar to that of large hospitals and the majority of small hospitals lack formal ASP that meet the CDC's core elements. The objective of this real-world implementation study was to assess the effectiveness of three ASP strategies of escalating intensity designed specifically for small hospitals within a vertically integrated healthcare delivery system.


Clinical Trial Description

The investigators designed a clustered randomized controlled intervention to evaluate 3 antibiotic stewardship strategies designed for small hospitals. Each hospital was randomized to one of three ASP interventions with increasing levels of intensity and intervention (Programs 1, 2, 3). The investigators felt that clinical equipoise about the effect of ASPs did not exist and randomizing to a no-intervention group was unacceptable. Antibiotic use was compared within each group before and after the intervention. In keeping with other real-world implementation studies, secondary analyses were planned to include an interrupted time series design to evaluate the impact of each strategy. Randomization of hospitals was stratified based on patient volume. Hospital administration and clinical leadership were not blinded to which ASP program they were randomly assigned to, but there were no public announcements. The intervention started March 2014 and ended June 2015. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03245879
Study type Interventional
Source Intermountain Health Care, Inc.
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date June 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05846399 - CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE) Phase 4
Completed NCT03349567 - Improving Antimicrobial-Prescribing in Emergency Departments N/A
Completed NCT04172207 - Antibiotic, Gingival-biopsy, and Oral-smear Samples.
Completed NCT05261152 - S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections Phase 4
Terminated NCT03089697 - Phase IIa Clinical Study of N-Rephasin® SAL200 Phase 2
Completed NCT03037112 - Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse N/A
Recruiting NCT03440216 - Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units N/A
Completed NCT03408457 - Influence of Perioperative Fluid Balance on Serum Concentrations of Antibiotics and Surgical Site Infections
Completed NCT04872400 - Acute Application of Antibiotic Powder in Open Fracture Wounds Phase 4
Completed NCT03114358 - Carbapenems De-escalation as Antimicrobial Stewardship N/A
Recruiting NCT05925309 - Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy N/A
Completed NCT03098485 - Healthy Patients & Effect of Antibiotics N/A
Completed NCT00272155 - An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice Phase 1/Phase 2
Completed NCT03280147 - 7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis Phase 3
Completed NCT04713436 - The Effects of Antibiotic Combinations on Stem Cells
Completed NCT03446053 - A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers Phase 1
Completed NCT04210713 - Neuroimmune Dysfunction in Alcohol Use Disorder Phase 1
Recruiting NCT05132829 - Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial Phase 4
Recruiting NCT05284318 - Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Completed NCT01855048 - A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers Phase 1